Navigation Links
PRA International Experts Present at the 45th Annual DIA Meeting
Date:6/17/2009

RALEIGH, N.C., June 17 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces it will present and exhibit at the 45th Annual Drug Information Association (DIA) meeting June 21 - 25 in San Diego, California. On June 21, Dr. Paul Starkey, PRA's Executive Director of Medical Affairs will make a presentation entitled "Obtaining Good Quality Data from Investigative Sites."

In addition, Dr. Starkey and other PRA medical, regulatory and operational experts will host Roundtable Sessions at PRA's booth # 811 on June 22nd and 23rd. The following topics will be addressed in one-hour interactive sessions:

  • Protocols, Waivers and Serious Breaches
  • Meeting The Requirements of Blending REMS Science & Operational Execution
  • Strategic Alliances to Ensure Product Development Success
  • Compassionate Use/Expanded Access Programs
  • Real-time Access to Data in Phase I

PRA will also have representatives from the following groups available to answer questions about PRA's capabilities in executing Phase I through Phase IV studies: Early Development Services, Medical Affairs, Data Management, Project Management, Clinical Operations, Regulatory, Late Phase Services, Executive Management and Business Development.

About PRA International

PRA International conducts clinical trials in more than 65 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. PRA has supported over 2,100 clinical trials through its 35 global offices.

PRA's therapeutic expertise, global reach and project experience, combined with extensive local kn
'/>"/>

SOURCE PRA International
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... Research Building (CRB), at the University of Mia... its sustainability components. The building was a...S. Green Building Council and verified by the Gree... the nation,s preeminent program for the design, c...aving a LEED certified building means we,re doing ...
(Date:12/1/2009)...wswire-FirstCall/ -- Air Products (NYSE: APD ) t...d sale of the assets of its polyurethane pre-polym...d Versathane® tradenames to COIM USA Inc., a ...icals producer COIM SpA. ,, Included in the sa...lsboro, N.J. Terms of the agreement are not being ...
(Date:12/1/2009)...ourages Older Persons and Healthcare Workers to Ge...n Authority Data ,, HARRISBURG, Pa., Dec. 1 /...ccine preventable deaths occur in those 65 and old...g to highlighted studies in the Pennsylvania Patie...y Advisory . ,, According to the Centers for Di...
(Date:12/1/2009)...e to successfully obtain information about the cos...e legislation intended to improve price transparen...come uninsured patients, researchers received pric...als they approached and the estimates received oft...ornia law, according to the findings published onl...
(Date:12/1/2009)...ths drop worldwide, but gains at risk. , ... Measles Initiative partners -- the American Red...ntion, the United Nations Foundation, UNICEF, and ...e the latest global health achievement during a pr...t 10:00 a.m. ET/16:00 CET. There will be time for...
Breaking Medicine News(10 mins):Health News:UM Clinical Research Building awarded prestigious LEED Building Certification 2Health News:Air Products Completes Sale of Polyurethane Pre-Polymers Business to COIM USA 2Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 2Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 3Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 4Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 5Health News:Hospital price transparancy laws in California fall short, study finds 2Health News:**MEDIA ADVISORY** Measles Initiative to Announce Major Achievement in Public Health 2
...ican Academy of Neurology finds conventionally rec...ve for treating nervous system Lyme disease. Howe...d treatment with antibiotics has any benefit in tr...ournal of the American Academy of Neurology. ...
...tment of Chemical Engineering makes it possible to...s for humans. The process is based on biosorption...to retain pollutants. It can be used to purify wat... agricultural residues, such as olive vegetable wa...
...other inflammatory rheumatic diseases are associat...ne explanation is a greater susceptibility to athe...o inflammation in healthy individuals as well, the...clerosis result from systemic inflammation, a hall...
...ti-center Phase II clinical trial suggest that ext...n treating patients with clinically active (OR sy...re refractory to immunosuppressants and/or anti-TN...rnoon at a scientific research session of Digestiv...
... the AMO Complete Moisture Plus Multi-Purpose Solu...he US has found that it could lead to an increased...e eye infection. The disease can cause pe...act lens users. The solution of concern is manuf...
...tal sex adversely impacts on a teen's mental healt...side effects of a teen's loss of virginity are con...kes those who have sex earlier than their peers an...a assistant professor of sociology, studied 8,563 ...
Other Medicine News:Health News:Antibiotics Highly Effective for Treating Lyme Disease 2Health News:Olive Stones to Depollute Industrial Sewage Water 2Health News:New Insights into Chronic Inflammation and Atherosclerosis 2Health News:ECP may Be Effective in Treating Crohn's Disease 2Health News:Contact Lens Wearers Warned Against Using AMO Solution 2Health News:Contact Lens Wearers Warned Against Using AMO Solution 3Health News:Loss of Virginity Could Prove Traumatic If Relationship Falls Apart Subsequently 2
(Date:12/1/2009)...CAGO, Dec. 1 At this year,s annual...ica (RSNA), Royal Philips Electronics ( PHG, AEX: ... a set of solutions that provides radiologists the... one workspot to help drive quality and efficiency...ps will also highlight new capabilities for its po...
(Date:12/1/2009)...EGO, Dec. 1 ADVENTRX Pha...ced that a new, recently completed preclinical stu...toxicity of ANX-514 and Taxotere® (docetaxel)...for ANX-514 in South Korea, independently conducte...ndent confirmation of the bioequivalence and compa...
(Date:12/1/2009)...WOOD CITY, Calif., Dec. 1 Codexis,...ship and the signing of its second agreement this ... world,s largest generic drug manufacturer. The n...al products. Codexis announced an earlier agreeme...eement, Teva will use Codexis biocatalysis technol...
Breaking Medicine Technology:Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 2Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 3Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 4ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 2ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 3Codexis Expands Collaboration with Teva 2Multiple Myeloma Genome Unlocked 53139 1Multiple Myeloma Genome Unlocked 53139 2Tabyat Partners LLC Launches iluvmydoc com 26amp 3B 238482 3B to Better Connect Patients with Doctors 53135 1Tabyat Partners LLC Launches iluvmydoc com 26amp 3B 238482 3B to Better Connect Patients with Doctors 53135 2Michigan IT Companies Helping the University of Miami Center for Patient Safety Tackle a Leading Cause of Death Using an RTLS Solution to Monitor Staf 53131 1Michigan IT Companies Helping the University of Miami Center for Patient Safety Tackle a Leading Cause of Death Using an RTLS Solution to Monitor Staf 53131 2Michigan IT Companies Helping the University of Miami Center for Patient Safety Tackle a Leading Cause of Death Using an RTLS Solution to Monitor Staf 53131 3
...g. 21 Johnson & Johnson Pharmaceutical,Research &... the U.S. Food,and Drug Administration (FDA) requi...the company,s New Drug Application (NDA) for DORIB... of hospital-acquired pneumonia,also known as noso...ated,pneumonia (VAP)., In response to the J&JPRD ...
... Enobia Pharma, an emerging biotech,company focus...ne,disorders, today announced that the first patie...s been dosed. Enobia is investigating Enzyme,Repla...nt of this rare and,often crippling genetic bone d... Under two separate protocols, ENB-0040 will be e...
Other Medicine Technology:FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia 2FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia 3FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia 4FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia 5Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia 2Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia 3
Rapimal MT Pf Dipstick
MALARIA STIX
PALUTOP
Malaria Device / Strip (2 line, PAN specific-pLDH)
Medicine Products: